Navigation Links
Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
Date:4/20/2009

harmaceuticals. "His deep experience in marketing will be key to us as we move towards commercialization with MP-376 and his expertise in structuring and managing complex collaborations will be invaluable as we are evaluating strategic commercialization options."

"I am excited to be joining Mpex at this critical time in the company's development," said Mark Wiggins. "I am very impressed with the progress Mpex has made in such a short time and believe there is a significant opportunity for MP-376 to become a therapy which can improve the quality of lives for patients suffering from cystic fibrosis or COPD. Exacerbations remain a significant problem in both of these diseases and MP-376 holds the promise of reducing the frequency of these events. As Mpex has retained global rights to MP-376 and the conclusion of the Phase II trials nears, I look forward to working with the rest of the management team to help Mpex achieve full potential for this new product opportunity."

About Mpex Pharmaceuticals

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance. Mpex's most advanced product candidate, MP-376, is a proprietary aerosol formulation of levofloxacin for nebulization that is being developed clinically as a maintenance therapy for the prevention of exacerbations in patients with cystic fibrosis and COPD. MP-376 is currently in Phase 2 studies for both indications. The company has also built a discovery and development platform and intellectual property estate around inhibitors of multi-drug resistant (MDR) efflux pumps (EPIs) found in m
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
2. Sunesis Pharmaceuticals Receives NASDAQ Notification
3. Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
4. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
5. Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
6. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
7. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
8. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
9. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
10. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
11. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) ... (eslicarbazepine acetate) for use as a once-daily adjunctive therapy ... epilepsy who are not satisfactorily controlled with conventional therapy. ... patients under 18 years of age. ... and according to Epilepsy Canada, it affects 0.6% of ...
(Date:7/11/2014)... July 11, 2014 Cayenne Medical, ... specializing in the soft tissue reconstruction segment, announced ... System for surgeries involving the shoulder and extremities. ... a novel, inserter-controlled deployment method. The unique delivery ... deployment, anchor pull-out, or anchor displacement (also commonly ...
(Date:7/10/2014)... 2014 Product and process impurities ... abundance and are often “lost in the noise,” ... Join presenters Dr. Rowel Tobias, Senior Scientist, Protein ... Head of Quality at Nanotherapeutics, Inc., to lear ... speed detection and quantitation while achieving the required ...
(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
Breaking Biology Technology:Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3
... ... (FTIR) instrument that is ideally suited for general, in situ reaction analysis understanding. The ... not. , ... -- METTLER TOLEDO announced the release of the ReactIR™ 15 reaction analysis and ...
... Despite ... employment added 20,000 jobs in April. News from the pharmaceutical industry was positive as well ... sales representatives . , ... (Vocus) -- Despite the U.S. unemployment rate edging higher for the first time in three ...
... Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider ... announced that it reached an agreement to sell its RapidTrace ® ... AB for $16.5 million in cash.   , ... "Divesting these product lines is a win-win ...
Cached Biology Technology:Improve Chemistry Understanding with Reaction Analysis 2The MedZilla Report for May 2010 - U.S. Unemployment Rate Edges Higher, But Healthcare Still Adds Jobs 2The MedZilla Report for May 2010 - U.S. Unemployment Rate Edges Higher, But Healthcare Still Adds Jobs 3The MedZilla Report for May 2010 - U.S. Unemployment Rate Edges Higher, But Healthcare Still Adds Jobs 4Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage 2Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage 3Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage 4
(Date:7/10/2014)... Albuquerque, and other major cities in New Mexico, nearly ... municipal wastewater rather than precious potable water supplies. Across ... of all golf courses receive treated effluent. Reusing the ... Additionally, golf courses and homeowners alike fertilize their lawns ... is nitrate. A New Mexico State University turfgrass expert ...
(Date:7/10/2014)... 2014  Pomerantz LLP has filed a class ... the "Company")(NYSE-MKT: PVCT) and certain of its officers.  ... Court, Middle District of Tennessee ... class consisting of all persons or entities who ... 17, 2013 and May 22, 2014, both dates ...
(Date:7/10/2014)... SPRINGS, Florida , July 1, 2014 ... wallets pave way for convenience and improved security: NXT-ID, Inc. ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) ... is pleased to announce that the second series of 30 ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
... -- An internationally-recognized gynecologic oncologist at St. Joseph,s Hospital and ... from a long-awaited global study of ovarian cancer should be ... month, the study reported that women who received early chemotherapy ... than those whose treatment is delayed. London-based, The ...
... - Dr. Jane Lubchenco, U.S. Under Secretary of Commerce for ... keynote speaker for a major academic conference on the ... the University of South Florida, the Florida Institute of Oceanography, ... Academic Task Force. Lubchenco, who played a leading role ...
... and streams supply the lifeblood of ecosystems across the globe, ... as a wide array of life forms in rivers and ... fish humans eat. But humans and nature itself are making ... to support fish species, according to new research by a ...
Cached Biology News:Gynecologist disputes findings 2Lubchenco to headline Gulf of Mexico Oil Spill Conference speaker lineup 2A river ran through it 2A river ran through it 3A river ran through it 4
... With increasing age, the autofluorescent pigment ... many cell types, including neurons. The ... the use of fluorescence microscopy in ... its broad excitation and emission spectra, ...
One unit is equal to 10Kb (insert DNA + vector). The final cost will increase or decrease according to the final assembled genome size. The price does not include genome annotation....
... to the family of calcium binding proteins such ... composed of an alpha and beta chain whereas ... S100 protein is also expressed in the antigen ... skin and interdigitating reticulum cells in the paracortex ...
Polyclonal Antibody to Golgin-67...
Biology Products: